April Hoang

News

Sports

Arts

Opinion

The Quad

Photo

Video

Illustrations

Cartoons

Graphics

The Stack

PRIME

Enterprise

Interactives

Podcasts

Games

Classifieds

Print issues

Budget Cuts Explained

Science & Health

Daily Bruin

Seller of cancer drug developed at UCLA to be bought over - Daily Bruin

Seller of cancer drug developed at UCLA to be bought over

max-snippet:-1, max-image-preview:large, max-video-preview:-1

robots

A pharmaceutical company will be purchasing the seller of Xtandi, a cancer treatment developed by UCLA, for $14 billion. Pfizer Inc. announced Monday that it will buy Medivation Inc., a biopharmaceutical company that develops disease treatments.

https://dailybruin.com/2016/08/22/seller-of-cancer-drug-developed-at-ucla-to-be-bought-over/

Saturday, March 7, 2026

IN THE NEWS:

Seller of cancer drug developed at UCLA to be bought over

By April Hoang

Aug. 22, 2016 8:16 p.m.